220 related articles for article (PubMed ID: 23650533)
1. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
2. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
[TBL] [Abstract][Full Text] [Related]
4. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
[TBL] [Abstract][Full Text] [Related]
5. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
[TBL] [Abstract][Full Text] [Related]
6. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
[TBL] [Abstract][Full Text] [Related]
7. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
[TBL] [Abstract][Full Text] [Related]
9. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
[TBL] [Abstract][Full Text] [Related]
10. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
11. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
[TBL] [Abstract][Full Text] [Related]
12. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
[TBL] [Abstract][Full Text] [Related]
13. Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway.
Yu C; Chen H; Zhao Y; Zhang Y
Med Sci Monit; 2021 Dec; 27():e931970. PubMed ID: 34911926
[TBL] [Abstract][Full Text] [Related]
14. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
[TBL] [Abstract][Full Text] [Related]
15. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
[TBL] [Abstract][Full Text] [Related]
16. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways.
Peng C; Liu HY; Zhou M; Zhang LM; Li XL; Shen SR; Li GY
Mol Cell Biochem; 2007 Sep; 303(1-2):141-9. PubMed ID: 17458518
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.
Zhang X; Liu H; Li B; Huang P; Shao J; He Z
BMC Cancer; 2012 Jun; 12():267. PubMed ID: 22727408
[TBL] [Abstract][Full Text] [Related]
18. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.
Jin X; Song X; Li L; Wang Z; Tao Y; Deng L; Tang M; Yi W; Cao Y
Mol Carcinog; 2007 Nov; 46(11):901-11. PubMed ID: 17477349
[TBL] [Abstract][Full Text] [Related]
19. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
[TBL] [Abstract][Full Text] [Related]
20. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
